| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.24▲ | 5.26▲ | 5.26▲ | 5.21▲ | 5.13▲ |
| MA10 | 5.25▲ | 5.26▲ | 5.30▼ | 5.03▲ | 5.70▼ |
| MA20 | 5.25▲ | 5.30▼ | 5.33▼ | 5.13▲ | 5.59▼ |
| MA50 | 5.26▲ | 5.29▼ | 5.11▲ | 5.82▼ | 6.27▼ |
| MA100 | 5.29▼ | 5.10▲ | 5.02▲ | 5.60▼ | 5.34▼ |
| MA200 | 5.32▼ | 5.01▲ | 5.35▼ | 6.46▼ | 4.10▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.008▼ | -0.026▼ | 0.081▲ | -0.057▼ |
| RSI | 60.207▲ | 49.815▼ | 53.450▲ | 48.959▼ | 45.862▼ |
| STOCH | 31.313 | 36.461 | 19.828▼ | 69.431 | 23.301 |
| WILL %R | 0.000▲ | -72.414 | -72.414 | -24.775▲ | -71.480 |
| CCI | 61.290 | -16.486 | -61.952 | 109.697▲ | -58.188 |
|
Wednesday, September 17, 2025 05:20 AM
Abstract Title: Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate ...
|
|
Sunday, September 07, 2025 08:52 AM
I rate Candel Therapeutics a Buy, seeing significant upside potential versus current valuation, driven by CAN-2409's blockbuster prospects in immunotherapy oncology. CAN-2409's strong phase III ...
|
|
Wednesday, September 03, 2025 11:21 PM
Fintel reports that on September 3, 2025, B of A Securities downgraded their outlook for Candel Therapeutics (NasdaqGM:CADL) from Buy to Neutral. Analyst Price Forecast Suggests 312.93% Upside As of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 5.38 | 5.38 | 5.20 | 5.27 | 638,397 |
| 24/09/25 | 5.36 | 5.485 | 5.27 | 5.43 | 624,744 |
| 23/09/25 | 5.30 | 5.49 | 5.23 | 5.29 | 952,020 |
| 22/09/25 | 4.82 | 5.29 | 4.80 | 5.23 | 869,762 |
| 19/09/25 | 5.00 | 5.03 | 4.80 | 4.81 | 930,733 |
| 18/09/25 | 4.94 | 5.02 | 4.84 | 4.94 | 726,190 |
| 17/09/25 | 4.94 | 5.03 | 4.82 | 4.84 | 777,944 |
| 16/09/25 | 4.85 | 4.95 | 4.82 | 4.85 | 406,690 |
| 15/09/25 | 4.75 | 4.86 | 4.602 | 4.85 | 789,221 |
| 12/09/25 | 4.89 | 4.9263 | 4.745 | 4.79 | 787,280 |
|
|
||||
|
|
||||
|
|